☆ 4.6 Article

Concordance of ASCL1, NEUROD1 and POU2F3 transcription factor-based subtype assignment in paired tumour samples from small cell lung carcinoma

HISTOPATHOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Cell Biology

Comparison of ASCL1, NEUROD1, and POU2F3 expression in surgically resected specimens, paired tissue microarrays, and lymph node metastases in small cell lung carcinoma

Takafumi Handa et al.

Summary: The aim of this study was to explore the impact of intratumoral heterogeneity of ASCL1, NEUROD1, and POU2F3 on the expression of these markers in surgical samples, tissue microarrays, and lymph node metastatic sites of small cell lung carcinoma (SCLC). Immunohistochemical examinations showed that positive expression of ASCL1, NEUROD1, and POU2F3 in tissue microarrays and lymph node metastatic sites was significantly correlated with that in surgical samples.

HISTOPATHOLOGY (2023)

Add to Collection

Review Oncology

Standardizing analysis of intra-tumoral heterogeneity with computational pathology

Ameesha Paliwal et al.

Summary: Many cancers, including glioblastoma, have the ability to adapt and change their biology to survive and grow under different conditions. However, systematic approaches to assess and document the variations within tumors are still in their early stages. This article discusses the current approaches and challenges in documenting intra-tumoral heterogeneity and introduces emerging computational methods that use artificial intelligence to overcome these limitations. By combining these techniques with molecular tools, a more systematic study of intra-tumoral heterogeneity can be conducted, leading to a better understanding and treatment of cancer.

GENES CHROMOSOMES & CANCER (2023)

Add to Collection

Article Pathology

Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance

Soohyun Hwang et al.

Summary: Utilizing whole sections of resected small cell lung cancer samples, this study investigated the clinicopathologic relevance and prognostic significance of molecular subtypes. It was found that YAP1 expression correlated with ASCL1 and NEUROD1 expression, and it was associated with non-small cell-like morphology and increased recurrence at mediastinal lymph nodes. YAP1 may serve as a poor prognostic factor in resected small cell lung cancer.

MODERN PATHOLOGY (2023)

Add to Collection

Review Cell Biology

Killing SCLC: insights into how to target a shapeshifting tumor

Kate D. Sutherland et al.

Summary: Small cell lung cancer (SCLC) is a rapidly growing, highly metastatic, and relatively immune-cold lung cancer subtype. It comprises multiple molecular subsets and exhibits tumor cell plasticity and phenotypic switching. This plasticity is associated with therapeutic resistance and immune-related gene expression.

GENES & DEVELOPMENT (2022)

Add to Collection

Article Oncology

Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers

Song Qu et al.

Summary: This study validated a new molecular subtype classification for small cell lung cancer (SCLC) and identified intriguing associations between subtypes and therapeutic markers. It demonstrated significant intratumoral heterogeneity, with different subtypes of tumors exhibiting distinct immunophenotypes.

JOURNAL OF THORACIC ONCOLOGY (2022)

Add to Collection

Article Oncology

Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study

Zsolt Megyesfalvi et al.

Summary: The tissue distribution and prognostic relevance of subtype-specific proteins in small-cell lung cancer was investigated. The study measured the expression of subtype-specific transcription factors and proteins in surgically resected samples and analyzed their correlation with therapeutic efficacy. The findings demonstrated differential survival rates among subtypes and identified high ASCL1 expression as a negative prognostic factor and high POU2F3 expression as a positive prognostic factor. Additionally, the study revealed correlations between subtype-specific protein abundances and sensitivity or resistance to chemotherapy drugs.

JOURNAL OF PATHOLOGY (2022)

Add to Collection

Article Oncology

Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC)

Xiao-Long Ding et al.

Summary: Small cell lung cancer (SCLC) can be divided into four subtypes based on the expression levels of ASCL1, NEUROD1, and POU2F3. These subtypes show different clinical characteristics and prognosis.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC

Marina K. Baine et al.

Summary: POU2F3 is a recent marker of a small cell lung carcinoma (SCLC) subtype related to chemosensory tuft cells (SCLC-P). The expression of POU2F3 is associated with low expression of standard neuroendocrine markers and can be helpful in supporting the diagnosis of SCLC in cases with minimal or absent neuroendocrine marker expression. SCLC-P exhibits distinct genomic alterations that may provide a novel avenue for therapeutic targeting.

JOURNAL OF THORACIC ONCOLOGY (2022)

Add to Collection

Article Oncology

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Carl M. Gay et al.

Summary: Despite the heterogeneity of small cell lung cancer (SCLC), four subtypes have been identified based on tumor expression data, each showing different responses to treatment. SCLC-I subtype benefits the most from immunotherapy, while other subtypes have vulnerabilities to different inhibitors. Matching tumor subtype to therapy and manipulating subtype switching during treatment may enhance response depth and duration for SCLC patients.

CANCER CELL (2021)

Add to Collection

Article Oncology

Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatment

Soohyun Hwang et al.

Summary: This study evaluated the molecular characteristics of SCLCs transformed after EGFR TKI treatment, finding that the SCLC-N subtype was prevalent in the transformed SCLCs. Patients who transformed to the SCLC-A type had longer overall survival and time to transformation compared to those who transformed to SCLC-N or SCLC-TN. Large-scale data are needed to confirm these findings.

TRANSLATIONAL LUNG CANCER RESEARCH (2021)

Add to Collection

Review Oncology

New Approaches to SCLC Therapy: From the Laboratory to the Clinic

John T. Poirier et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

Add to Collection

Article Oncology

MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate

Abbie S. Ireland et al.

CANCER CELL (2020)

Add to Collection

Article Oncology

SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization

Marina K. Baine et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

Add to Collection

Article Oncology

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Nicolas Marcoux et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Review Oncology

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

Charles M. Rudin et al.

NATURE REVIEWS CANCER (2019)

Add to Collection

Article Cell Biology

POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer

Yu-Han Huang et al.

GENES & DEVELOPMENT (2018)

Add to Collection

Article Oncology

Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas

June-Koo Lee et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Comprehensive genomic profiles of small cell lung cancer

Julie George et al.

NATURE (2015)

Add to Collection

Article Oncology

Small-Cell Lung Cancers in Patients Who Never Smoked Cigarettes

Anna M. Varghese et al.

JOURNAL OF THORACIC ONCOLOGY (2014)

Add to Collection

Article Genetics & Heredity

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

Charles M. Rudin et al.

NATURE GENETICS (2012)

Add to Collection

Article Oncology

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database

Ramaswamy Govindan et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.